ProCE Banner Activity

Contemporary Management of HIV: Integrating New Data From Fall 2019 HIV Conferences

Slideset Download
Conference Coverage
In this downloadable slideset, review key HIV data from the 2019 IDWeek and EACS meetings on PrEP outcomes, ART efficacy and tolerability in first-line and switch settings, metabolic and weight considerations with HIV therapy, and regimen selection during pregnancy.

Released: December 05, 2019

Expiration: December 03, 2020

No longer available for credit.

Share

Faculty

Joseph J. Eron

Joseph J. Eron, Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Princy N. Kumar

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

David A. Wohl

David A. Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

ViiV Healthcare

Program Director Disclosure

Program Director

Joseph J. Eron, Jr., MD

Professor of Medicine
University of North Carolina School of Medicine
Director, AIDS Clinical Trials Unit
University of North Carolina
Chapel Hill, North Carolina

Joseph J. Eron, Jr., MD, has disclosed that he has received consulting fees from Gilead Sciences, Janssen, Merck, and ViiV and funds for research support from Gilead Sciences, Janssen, and ViiV.

Princy N. Kumar, MD

Professor of Medicine and Microbiology
Division of Infectious Diseases
Georgetown University Hospital
Division Chief
Division of Infectious Diseases and Travel Medicine
Department of Internal Medicine
Medstar Georgetown University Hospital
Washington, DC

Princy N. Kumar, MD, FIDSA, MACP, has disclosed that she has received consulting fees from GlaxoSmithKline/ViiV, Janssen/Johnson & Johnson, Merck, and Theratechnologies; has received funds for research support from Gilead Sciences, GlaxoSmithKline/ViiV, Janssen/Johnson & Johnson, Merck, and Theratechnologies; and has ownership interest in Gilead Sciences, GlaxoSmithKline/ViiV, Janssen/Johnson & Johnson, and Merck.

Faculty Disclosure

Primary Author

David A. Wohl, MD

Associate Professor of Medicine
School of Medicine
Site Leader, AIDS Clinical Trials Unit-Chapel Hill
University of North Carolina at Chapel Hill
Director, North Carolina AIDS Training and Education Center
Chapel Hill, North Carolina
Co-Director for HIV Services
North Carolina Department of Correction
Raleigh, North Carolina

David A. Wohl, MD, has disclosed that he has served on advisory boards for and received funds for research support from Gilead Sciences, Merck, and ViiV Healthcare.